10/18/22

Gene therapy can make a real impact on global health but we need equitable access, say experts

Written by Kevin Doxzen, in collaboration with Thunderbird School of Global Management and the Sandra Day O’Connor College of Law at Arizona State University, is a recipient of the World Economic Forum’s Hoffmann Fellowship for the Fourth Industrial Revolution, which offers early-career academics the opportunity to work at the intersection of society, science and technology. Read more about his research. 

10/18/22

Accelerating Global Access to Gene Therapies: Case Studies from Low- and Middle-Income Countries

Gene therapy is at the forefront of modern medicine. By making precise changes to the human genome, these sophisticated technologies can potentially lead to one-time lifelong cures. As of mid-2022, more than 2,000 gene therapies were in development worldwide, contributing to a global market value that is expected to reach nearly $20 billion by 2027.

Subscribe to Global Impact and Engagement